Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study of the Efficacy and Safety of Vaginally Applied Dequalinium Chloride (10 mg) and Orally Applied Metronidazole (2 x 500 mg) in the Treatment of Bacterial Vaginosis

NCT05788991 is registered in ClinicalTrials.gov with Medinova AG as lead sponsor.

NCT NCT05788991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05788991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study of the Efficacy and Safety of Vaginally Applied Dequalinium Chloride (10 mg) and Orally Applied Metronidazole (2 x 500 mg) in the Treatment of Bacterial Vaginosis
Lead sponsor
Medinova AG
Phase
Phase 4
Overall status
Terminated
Start date
July 26, 2021
Completion date
August 25, 2022
Enrollment
151 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial vaginosis, vaginal diseases, vaginal infection